Senseonics (SENS)
(Delayed Data from AMEX)
$0.35 USD
-0.01 (-3.39%)
Updated Sep 23, 2024 04:00 PM ET
4-Sell of 5 4
F Value B Growth A Momentum C VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
SENS 0.35 -0.01(-3.39%)
Will SENS be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for SENS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SENS
Sonendo, Inc. (SONX) Reports Q2 Loss, Tops Revenue Estimates
SOPHiA GENETICS SA (SOPH) Reports Q2 Loss, Lags Revenue Estimates
SENS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Senseonics' (SENS) Deal With Mercy to Drive Eversense CGM Sales
Clover Health Investments, Corp. (CLOV) Reports Q1 Loss, Tops Revenue Estimates
Senseonics Holdings (SENS) Reports Q4 Loss, Tops Revenue Estimates
Other News for SENS
Eversense 365 Receives FDA Clearance: The World?s First One Year CGM
Eversense 365 Receives FDA Clearance: The World?s First One Year CGM
Senseonics Eversense 365 glucose monitor cleared in the U.S.
Senseonics receives FDA clearance for Eversense 365 CGM system
Senseonics announces FDA clearance for Eversense 365 CGM system